Catalyst Wire Dossier Catalyst Wire Dossier

MVA-BN Smallpox vaccine

Modified Vaccinia Ankara-Bavarian Nordic · Bavarian Nordic
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for MVA-BN Smallpox vaccine, covering 2019-12-05 to 2020-04-02. Get the full timeline:

Most recent: Clinical Trial Update: Randomized, Open-label Phase II Trial to Assess the Safety and Immunogenicity of MVA-BN Smallpox Vaccine in Immunocompromised Subjects With HIV Infection [Phase 2]

See pricing